Investment
Features
FeesSafety
Academy
More
Pluang+

SpaceX plans Starship's 14th test flight to orbit upper stage and launch 26 Starlink V3 satellites on Sept 22.

Market News
15 Sep 2026
TechCrunch
View Source
Bullish
SpaceX plans Starship's 14th test flight to orbit upper stage and launch 26 Starlink V3 satellites on Sept 22.

SpaceX is set to conduct the 14th test flight of its Starship rocket on September 22, aiming to put the upper stage into Earth orbit for the first time. This flight will also deploy 26 third-generation Starlink satellites, marking the first Starship launch to generate revenue for SpaceX's launch division. The company has made hardware and software modifications to address previous booster issues but will not attempt to catch the booster or upper stage during this flight. Success would be a major milestone toward retiring Falcon 9 and Falcon Heavy rockets in favor of Starship for frequent, reliable launches.

SpaceX's upcoming Starship orbital test flight on September 22 provides context for technology sector activity on Pluang. As of September 16, 2026 00:11 WIB, 68 of 150 priced Technology-sector US stocks rose while 82 fell. Notable movers include GoPro Inc (GPRO) at USD 1.29 with a -4.44% change, Expensify Inc (EXFY) at USD 2.38 with a +4.39% change, and Hut 8 Corp (HUT) at USD 87.16 with a -4.36% change.

More News

WasabiCard advances global payment partnerships and highlights APAC stablecoin payment needs at TOKEN2049.

WasabiCard advances global payment partnerships and highlights APAC stablecoin payment needs at TOKEN2049.

WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...

Market News
Bullish
46 minutes ago
Next generation antibody therapeutics market to grow to $5.76B by 2035, driven by cancer and rare disease treatments

Next generation antibody therapeutics market to grow to $5.76B by 2035, driven by cancer and rare disease treatments

The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...

Market News
Bullish
1 hour ago
Global insurtech market to hit $638B by 2035, driven by AI, cloud, and automation with 41.45% CAGR

Global insurtech market to hit $638B by 2035, driven by AI, cloud, and automation with 41.45% CAGR

The global insurtech market is projected to grow from $14 billion today to $638 billion by 2035, at a compound annual growth rate of 41.45%. This rapid expansion is fueled by the adoption of AI, blockchain, cloud computing, machine learning, IoT, and...

Market News
Bullish
1 hour ago
EV wiring harnesses and connectors market to hit $29.43B by 2035, driven by high-voltage systems and EV growth

EV wiring harnesses and connectors market to hit $29.43B by 2035, driven by high-voltage systems and EV growth

The global market for wiring harnesses and connectors in electric vehicles is projected to grow from $8.53 billion in 2025 to $29.43 billion by 2035, at a CAGR of 12.83%. This growth is fueled by increasing EV production, adoption of battery electric...

Market News
Bullish
1 hour ago
Decentralized Clinical Trials market to reach $18.8B by 2030 with 13.7% CAGR driven by AI and digital tech.

Decentralized Clinical Trials market to reach $18.8B by 2030 with 13.7% CAGR driven by AI and digital tech.

The global Decentralized Clinical Trials (DCT) market, valued at $8.8 billion in 2025, is projected to grow to $18.8 billion by 2030, expanding at a CAGR of 13.7%. Growth is fueled by adoption of AI, wearables, cloud platforms, and flexible remote st...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App